Corline Biomedical AB   Report issue

For profit Phase 1
Founded: Uppsala Sweden (1991)

Organization Overview

First Clinical Trial
2019
NCT03773211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Corline Biomedical AB